Author: admin

  • UK offers to mediate in unions’ complaint against McDonald’s – report

    UK offers to mediate in unions’ complaint against McDonald’s – report

    A governmental body in the UK has offered to mediate after a group of trade unions accused McDonald’s of failing to properly handle harassment allegations across its restaurants and franchises, BBC has reported.

    This comes after five unions lodged a complaint with the UK National Contact Point (NCP), an independent body within the Department for Business and Trade staffed by civil servants and external advisers.

    The unions allege the fast-food chain breached international labour standards by not adequately addressing sexual harassment nationwide.

    The report stated that following an initial review, the NCP said the case should proceed and offered to mediate between the unions and McDonald’s.

    The complaint follows a BBC investigation that detailed allegations of a toxic workplace environment at the fast-food chain, with workers reporting harassment.

    The trade unions, alongside the Corporate Justice Coalition, said their complaint was filed in response to that reporting.

    In its submission, the group points to “further evidence of persistent, deeply rooted gender-based discrimination” and argues this breaches Organisation for Economic Co-operation and Development (OECD) guidelines.

    It also cites “repeated episodes” of harassment involving McDonald’s staff, “most of them teenagers”, and alleges managers did not act to stop the behaviour.

    The UK Department for Business and Trade said accepting the complaint does not represent a finding against McDonald’s and does not indicate it believes the company has failed to follow OECD guidelines.

    It added that the offer of mediation is voluntary, and if either side refuses to participate, the NCP will move to a further examination of the complaint.

    After the BBC report, McDonald’s apologised and set up a new team to handle complaints.

    More than 160 people have since contacted the BBC with allegations while the Equality and Human Rights Commission (EHRC) has received 300 reported incidents of harassment.

    In addition, over 700 current and former junior employees are taking legal action against the company.

    Commenting on the latest developments, a McDonald’s spokesperson told BBC: “We are aware of the NCP’s initial assessment and continue to engage constructively with the OECD process. We are reviewing the information and considering next steps.”

    “UK offers to mediate in unions’ complaint against McDonald’s – report” was originally created and published by Verdict Food Service, a GlobalData owned brand.

     


    The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

    Continue Reading

  • Pakistan to stay in Pak-China-Afghan forum, seeks action against terrorists

    Pakistan to stay in Pak-China-Afghan forum, seeks action against terrorists

    FO says Kabul must give guarantees, rejects India’s claims and JF-17 deal reports


    ISLAMABAD:

    Continue Reading

  • January: Bristol scientists discover early sponges were soft | News and features

    January: Bristol scientists discover early sponges were soft | News and features

    Sponges are among earth’s most ancient animals, but exactly when they evolved has long puzzled scientists. Genetic information from living sponges, as well as chemical signals from ancient rocks, suggest sponges evolved at least 650 million…

    Continue Reading

  • Approval for Cefiderocol in China| 塩野義製薬

    OSAKA, Japan, January 8, 2026 – Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced that its group company, Shionogi China Co., Ltd. (Head Office: Shanghai, China; Chairman: Hirofumi Nagatome), has received approval from the National Medical Products Administration (NMPA) of China for cefiderocol (generic name: Cefiderocol Sulfate Tosylate for Injection; hereinafter “cefiderocol”) for the treatment of complicated urinary tract infections including pyelonephritis caused by Gram-negative bacteria.

     

    This approval is based on positive results from an international multicenter clinical study¹ and a randomized, double-blind, multicenter study² conducted in China. In both studies, which aimed to verify non-inferiority to the comparator drug, cefiderocol demonstrated non-inferiority to imipenem/cilastatin and achieved the primary endpoint. Furthermore, no new safety concerns were identified, and cefiderocol was well tolerated.

     

    Antimicrobial resistance (AMR) occurs when bacteria develop resistance to antibiotics, making infections harder to treat. AMR is often referred to as a “silent pandemic” and is recognized as one of the most pressing global public health threats requiring urgent action3. In 2021, AMR was estimated to have caused 1.14 million deaths worldwide4. Without coordinated international efforts, it is projected that more than 39 million lives could be lost over the next 25 years5. Meanwhile, treatment options remain limited, making this an area of high unmet medical need. With this approval, cefiderocol is expected to provide a new treatment option for patients in mainland China suffering from difficult-to-treat complicated urinary tract infections.

     

    Shionogi has identified “Protecting people from the threat of infectious diseases” as a material issue and is committed to realizing total care for infectious diseases. We will continue to work toward delivering essential anti-infective treatments to patients worldwide as quickly as possible, contributing to global efforts to combat AMR. For more information on Shionogi’s initiatives against AMR, please visit.

    Clich here to learn more about our efforts to address antimicrobial resistance.

     

     

    About Cefiderocol

    Cefiderocol is an antibiotic that penetrates the outer membrane of Gram-negative bacteria, including multidrug-resistant strains, to exert its antibacterial activity. As of December 2025, cefiderocol is marketed in 27 countries and regions, including Japan, Europe, U.S., Taiwan and China. It is listed on the WHO Model List of Essential Medicines, demonstrating its continued importance in improving outcomes for patients with some of the most difficult-to-treat Gram-negative infections. Prior to this approval, the Hainan Provincial Medical Products Administration had authorized its clinical use in the Boao Lecheng International Medical Tourism Pilot Zone in China6.

     

     

     

    References

    1.       Press release: January 12, 2017

    2.       Chinese Clinical Trial Registry: Phase III clinical trial registration number CTR20223300

    3.       Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399: 629–55.

    4.       GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024 Sep 28;404(10459):1199-1226. doi: 10.1016/S0140-6736(24)01867-1. Epub 2024 Sep 16. PMID: 39299261.

    5.       Antimicrobial resistance (who.int) WHO. Antimicrobial resistance. Who.int. Published October 13, 2020.

    6.       Press release: August 5, 2024

     

    Forward-Looking Statements

    This announcement contains forward-looking statements. These statements are based on expectations in light of the information currently available, assumptions that are subject to risks and uncertainties which could cause actual results to differ materially from these statements. Risks and uncertainties include general domestic and international economic conditions such as general industry and market conditions, and changes of interest rate and currency exchange rate. These risks and uncertainties particularly apply with respect to product-related forward-looking statements. Product risks and uncertainties include, but are not limited to, completion and discontinuation of clinical trials; obtaining regulatory approvals; claims and concerns about product safety and efficacy; technological advances; adverse outcome of important litigation; domestic and foreign healthcare reforms and changes of laws and regulations. Also for existing products, there are manufacturing and marketing risks, which include, but are not limited to, inability to build production capacity to meet demand, lack of availability of raw materials and entry of competitive products. The company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

     

    For Further Information, Contact:

    SHIONOGI Website Inquiry Form: https://www.shionogi.com/global/en/contact.html

    Continue Reading

  • Economic Burden of Diabetes Set to Soar Globally

    Economic Burden of Diabetes Set to Soar Globally

    THE ECONOMIC burden of diabetes is far greater than previously recognised and is set to place sustained pressure on health systems and societies worldwide, according to a large global modelling study spanning 204 countries and…

    Continue Reading

  • NHS England » Bounce back in winter viruses as NHS top doctor warns ‘the worst is far from over’

    NHS England » Bounce back in winter viruses as NHS top doctor warns ‘the worst is far from over’

    Christmas and New Year gatherings may have caused a bounce back in winter viruses, as the health service also grapples with a vicious cold snap.

    Figures published today show that the number of patients in hospital beds with…

    Continue Reading

  • The Tech That Will Invade Our Lives in 2026 – The New York Times

    1. The Tech That Will Invade Our Lives in 2026  The New York Times
    2. The Technology Trends Quietly Redefining 2026  TechPluto
    3. 5 Upcoming Smartphones That Spark Excitement for 2026  Observer Voice
    4. Car that will run 1,000 km on full charge: Make calls from…

    Continue Reading

  • PM chairs the Roundtable with Indian AI Start-Ups

    PM chairs the Roundtable with Indian AI Start-Ups

    12 Indian AI Start-ups, who have qualified for the AI for ALL: Global Impact Challenge in the India AI Impact Summit 2026, present their ideas and work

    These Start-ups are working in a diverse set of areas like healthcare, multilingual LLMs, material research, data analytics, engineering simulations among others

    Start-ups highlight the rapid growth and vast future potential of the AI sector and observe that the centre of gravity of AI innovation and deployment is beginning to shift towards India

    Start-ups commended India’s strong commitment to advancing the artificial intelligence ecosystem

    PM emphasises that startups and AI entrepreneurs are the co-architects of India’s future

    PM suggests that Indian AI models should promote local and indigenous content and regional languages

    PM emphasises the need to ensure that Indian AI models are ethical, unbiased, transparent, and based on data privacy principles

    PM assures full government support for the success of their AI models

    Prime Minister Shri Narendra Modi chaired the Roundtable with Indian AI Start-Ups at his residence at 7, Lok Kalyan Marg earlier today.

    Ahead of the India AI Impact Summit 2026 to be held in India next month, 12 Indian AI start-ups who have qualified for the AI for ALL: Global Impact Challenge in the Summit attended the roundtable and presented their ideas and work.

    These Start-ups are working in a diverse set of areas including Indian language foundation models, multilingual LLMs, speech-to-text, text-to-audio and text-to-video; 3D content using generative AI for e-commerce, marketing, and personalized content creation; engineering simulations, material research and advanced analytics for data-driven decision-making across industries; healthcare diagnostics and medical research, among others.

    The AI Start-Ups commended India’s strong commitment to advancing the artificial intelligence ecosystem in the country. They highlighted the rapid growth and vast future potential of the AI sector, observing that the centre of gravity of artificial intelligence innovation and deployment is beginning to shift towards India. The leaders said that India now offers a robust and enabling environment for AI development, firmly placing the country on the global AI map.

    During the meeting, Prime Minister highlighted the importance of artificial intelligence in bringing about transformation in society. He noted that India will host the India AI Impact Summit next month, through which the country will play a major role in the technology sector. He highlighted that India is making efforts to bring about a transformation with & leveraging AI.

    Prime Minister emphasised that startups and AI entrepreneurs are the co-architects of India’s future and said that the country has immense capacity for both innovation and large-scale implementation. He added that India should present a unique AI model to the world that reflects the spirit of “Made in India, Made for the World.”

    Prime Minister said that the world’s trust in India is the country’s biggest strength. He emphasised the need to ensure that Indian AI models are ethical, unbiased, transparent, and based on data privacy principles. He said startups should also work towards global leadership from India, and noted that India can promote affordable AI, inclusive AI, and frugal innovation globally. He also suggested that Indian AI models should be distinct and should promote local and indigenous content and regional languages.

    The meeting was attended by CEOs, Heads and representatives of Indian AI start-ups including Avataar, BharatGen, Fractal, Gan, Genloop, Gnani, Intellihealth, Sarvam, Shodh AI, Soket AI, Tech Mahindra and Zenteiq. Union Minister for Electronics and Information Technology, Shri Ashwini Vaishnaw and Minister of State, Shri Jitin Prasada were also present during the meeting.


    Continue Reading

  • Infinix Unveils Satellite Calling Phones and Bladeless Cooling Tech

    Infinix Unveils Satellite Calling Phones and Bladeless Cooling Tech

    Infinix has also introduced its new HydroFlow Liquid Cooling Architecture. This functionality is useful for maintaining temperature and boosting overall performance on all upcoming smartphone models.

    The cooling system uses a…

    Continue Reading

  • Trump's "Donroe Doctrine" sets U.S. on collision course with Russia and China – Axios

    1. Trump’s “Donroe Doctrine” sets U.S. on collision course with Russia and China  Axios
    2. Venezuela and Beyond: Trump’s ‘America First’ Rhetoric Masks a Neo-Imperialist Streak  Council on Foreign Relations
    3. What Is the Monroe Doctrine, and How Is…

    Continue Reading